Ipilimumab - Articles - Scientific Research Publishing

Healthcare Resource Utilization and Associated Costs in Patients with Advanced Melanoma Receiving First-Line Ipilimumab (Articles)

Ahmad Tarhini, Shelby L. Corman, Sumati Rao, Kim Margolin, Xiang Ji, Sonam Mehta, Marc F. Botteman

Journal of Cancer Therapy Vol.6 No.10，September 4, 2015

DOI: 10.4236/jct.2015.610091 3,476 Downloads 4,924 Views Citations
Treatment Patterns and Healthcare Costs among U.S. Patients with Advanced Melanoma Initiating Subsequent Systemic Therapy Following Use of Ipilimumab (IPI) (Articles)

Elisabetta Malangone-Monaco, Tony Okoro, Beata Korytowsky, Amy Stanford, Stephen Johnston, William Johnson, Sigrun Hallmeyer

Journal of Cancer Therapy Vol.7 No.5，May 11, 2016

DOI: 10.4236/jct.2016.75036 2,988 Downloads 4,624 Views Citations
A Real-World Observational Study of Patients with Advanced Melanoma Receiving First-Line Ipilimumab in a Community Practice Setting (Articles)

Debra A. Patt, Debra Rembert, Menaka Bhor, Debajyoti Bhowmik, Sumati A. Rao

Journal of Cancer Therapy Vol.5 No.12，October 23, 2014

DOI: 10.4236/jct.2014.512110 4,318 Downloads 6,201 Views Citations
Long-Term Persistent Absolute Insulin Secretion Deficiency in Diabetes Induced by Immune Checkpoint Inhibitors (Articles)

Moctar Bah, Clara Bouché, Jean-François Gautier

Open Journal of Endocrine and Metabolic Diseases Vol.13 No.12，December 27, 2023

DOI: 10.4236/ojemd.2023.1312017 103 Downloads 359 Views Citations
Immune Checkpoint Inhibitor Related Neuropathic Adverse Effects on Cancer Patients (Articles)

Samrat Khanal, Haijun Zhang

Journal of Biosciences and Medicines Vol.7 No.6，May 31, 2019

DOI: 10.4236/jbm.2019.76001 963 Downloads 2,756 Views Citations
Hypercalcemia and Granulomatous-Like Lesions in a Patient with Melanoma after Treatment with Immunotherapy: Case Report (Articles)

Rebecca A. Takele, Alya Z. Aboulhosn, Prajwol Pant, Paul Laflam

Case Reports in Clinical Medicine Vol.11 No.5，May 27, 2022

DOI: 10.4236/crcm.2022.115028 166 Downloads 853 Views Citations

	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

All	Title	Abstract	Keywords
DOI	Author	Journal	Affiliation
ISSN	Subject

	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Browse Subjects

Publish with us

Home

About SCIRP

Service

Policies